Home βΊ Calculator βΊ RGEDF Dividend Calculator 2026
RGEDF Dividend DRIP Calculator 2026
5.37% YieldHealthcareGedeon Richter PLC Β· OTC
Price: $40.13 Β· Annual div: $2.15/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
π‘ What-if scenarios
Click to apply scenario to the calculator
π― When RGEDF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your RGEDF snowball π
$10,000 in RGEDF β $7.54M in 10 years Β· $163,610.32/month
About Gedeon Richter PLC (RGEDF) β Dividend Analysis 2026
Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. The company offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital therapeutic solution to enhance women's lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, the company produces various over-the-counter products for various health problems comprising Panangin for heart support; Escapelle and Postinor, which are emergency contraceptive pills; Stopdiar and Nifuroxazide to treat diarrhea; RICHTER CycleBalance for infertility and PCOS; Curiosin for wound healing; Groprinosin for antiviral and immunostimulant; Folik, a pregnancy supplement; Moilec for back and joint pain; Fasconal, a pain relief tablet; Lordestin for allergies; Magnezin, a magnesium supplement; Aflamil, an anti-inflammatory and antirheumatic cream; and Oralsept, a sore throat and local anesthetic. Further, it engages in the provision of financial accounting, social and welfare, portfolio and management, catering, carriage transportation, engineering, quality control, asset management, and biotechnological manufacturing and research services; pharmaceutical retail; trading of biotech products; and sale of medical equipment. The company has strategic co-development and license agreement with Adalvo Ltd. for a proposed bioequivalent to Semaglutide injection, a GLP-1 receptor agonist indicated for chronic weight management. Additionally, it has a strategic research collaboration with FimmCyte AG for the development of first-in-class antibody, ΒFMC2', for the treatment of endometriosis. The company was founded in 1901 and is headquartered in Budapest, Hungary.
Compare RGEDF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full RGEDF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open RGEDF position with:
π RGEDF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold RGEDF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 5.37% | 2.57% | $537 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 4.56% | 1.76% | $456 / yr |
| πΊπΈ US Taxable (20%) | 20% | 4.30% | 1.50% | $430 / yr |
| π¬π§ UK ISA | 0% | 5.37% | 2.57% | $537 / yr |
| π¬π§ UK Taxable | 8.75% | 4.90% | 2.10% | $490 / yr |
| π¨π¦ TFSA | 0% | 5.37% | 2.57% | $537 / yr |
| π¨π¦ CA Taxable | 25% | 4.03% | 1.23% | $403 / yr |
| π¦πΊ Super (pension) | 15% | 4.56% | 1.76% | $456 / yr |
| π¦πΊ AU Taxable | 30% | 3.76% | 0.96% | $376 / yr |
| π©πͺ DE Taxable | 26.375% | 3.95% | 1.15% | $395 / yr |
| π«π· FR Taxable | 30% | 3.76% | 0.96% | $376 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
π― RGEDF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.15/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
π RGEDF Dividend Payment Schedule
RGEDF pays quarterly β 4 times per year. Next ex-div: TBD.
π RGEDF vs Healthcare Benchmarks
How RGEDF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RGEDF sourced from FMP /financial-growth endpoint β real data, not estimates.
ποΈ RGEDF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RGEDF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Gedeon Richter PLC (RGEDF) is currently trading at $40.13, 7% below its 52-week high. The current dividend yield is 5.37% based on an annual payout of $2.15 per share.
RGEDF (Gedeon Richter PLC) β 5.37% Dividend Yield Analysis
Gedeon Richter PLC (RGEDF) is a healthcare stock currently trading at $40.13 with a dividend yield of 5.37%. The company pays an annual dividend of $2.15 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, RGEDF has grown its dividend at a compound annual rate of 100.0%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only β not financial advice.